Screener
SAB Biotherapeutics SABS Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS-$0.21Beat by $0.38
Revenue estimate$100.0K
EPS estimate-$0.59
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$125.0K
EPS estimate-$0.27
Versus estimates
Diluted EPS
FAQ
- When did SAB Biotherapeutics report Q3 2025 earnings?
- SAB Biotherapeutics (SABS) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were SAB Biotherapeutics's Q3 2025 revenue and EPS?
- SAB Biotherapeutics reported eps of $-0.21 for Q3 2025.
- Did SAB Biotherapeutics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.59 by $0.38.
- How did SAB Biotherapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 81.3% from $-1.12.
- Where can I find SAB Biotherapeutics's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-280572) directly on SEC EDGAR. The filing index links above go to sec.gov.
